On-Demand and Enduring Materials
MD Anderson is pleased to offer online learning opportunities for physicians and health care providers. These online CME programs range from communication skills to the latest advances in the field of oncology and come with specific instructions for completion and obtaining credit.
On-Demand and Other Sponsored Online CME Activities
Art and Science of Managing the New Melanoma Landscape - 7th Annual Collaborative Conference
October 17, 2020 thru April 16, 2020
3.75 AMA PRA Category 1 Credits TM from October 17, 2020 – April 16, 2021
Annual Multidisciplinary Cancer Care Conference: Bridging Oncology and Primary Care (Upcoming)
From February, 2021- August, 2021
Acute Myeloid Leukemia: What's New on the Horizon - T1010-E
1.00 AMA PRA Category 1 CreditTM from April 22, 2020 thru April 22, 2021
While guidelines for AML management are widely available, the treatment paradigm for AML is undergoing a rapid change in the settings of frontline treatment of younger patients with AML, older patients with AML not fit for intensive chemotherapy, and relapsed/refractory AML. Ensuring adjustments of these changes will avoid care limitations in terms of the clinical support team’s ability to utilize recent advances and adapt to changes in practice. Clinicians may not be adequately prepared to effectively and safely employ new therapies or discuss promising investigational agents with their patients. Moreover, clinicians may not be adequately knowledgeable regarding emerging clinically relevant biomarkers associated with both approved and investigational therapy choices for their patients with AML.
1.00 AMA PRA Category 1 CreditTM from July 10, 2020 thru July 10, 2021
This integrated portal enhances learner access to tailored education. Built on a powerful web platform, Healio provides physicians and other health care professionals with personalized content based on their needs and areas of interest. The Healio Education Lab is a one stop resource for specialty specific education and quality content from the most trusted website dedicated to physician news, information and education.
2.00 AMA PRA Category 1 Credits TM from August 25, 2020 to August 25, 2021.
Utilization of appropriate combination therapies alongside immunotherapy agents for treatment of RCC Practical management strategies for immune-related adverse events arising from use of immunotherapy agents for treatment of RCC.
1.25 AMA PRA Category 1 CreditsTM from July 10, 2020 to July 10, 2021
Utilization of appropriate combination therapies alongside immunotherapy agents for treatment of RCC Practical management strategies for immune-related adverse events arising from use of immunotherapy agents for treatment of RCC
.50 AMA PRA Category 1 Credits TM from July 10, 2020 to July 10, 2021
Utilization of appropriate combination therapies alongside immunotherapy agents for treatment of RCC Practical management strategies for immune-related adverse events arising from use of immunotherapy agents for treatment of RCC
.50 AMA PRA Category 1 Credits TM from July 10, 2020 to July 10, 2021
Utilization of appropriate combination therapies alongside immunotherapy agents for treatment of RCC Practical management strategies for immune-related adverse events arising from use of immunotherapy agents for treatment of RCC.
4.50 AMA PRA Category 1 Credits TM from November 17, 2020 thru November 17, 2021
The proposed CME certified activity is designed to deliver knowledge-based education regarding novel and
emerging therapies as well as competency focused education to support precision medicine for breast cancer
patients. The content will synthesize the data around HER2+ breast cancer, including emerging data on antibody drug conjugates and the future place in the treatment, biomarker testing. Content will also address interpreting results to inform treatment decisions, while providing practical guidance to apply this knowledge in a real-world setting
Optimizing Shared Decision Making in Lung Cancer (Today's Clinical Reality) E117619-1
.50 AMA PRA Category 1 CreditsTM from January 2, 2020 thru January 2, 2021
This activity will assess shared decision making between physician and patients. Patient and physician interviews/questionnaires will be utilized to measure the concordance between oncologist communication and treatment intentions and lunch cancer patient comprehension and treatment intentions based on National Quality Partners PlaybookTM guidance and recommendations.
Optimizing Shared Decision Marking in Lung Cancer (Strategies for Enhancing your Practice) E117619-2
.50 AMA PRA Category 1 CreditsTM .50 AMA PRA Category 1 CreditsTM in the area of medical ethics and/or professional responsibility. from January 2, 2020 thru January 2, 2021
This activity will assess shared decision making between physician and patients. Patient and physician interviews/questionnaires will be utilized to measure the concordance between oncologist communication and treatment intentions and lunch cancer patient comprehension and treatment intentions based on National Quality Partners PlaybookTM guidance and recommendations.
Optimimizing Shared Decision Marking in Lung Cancer - E117619
No CME Credits
Provider Tobacco and Nicotine Counseling for Adults and Adolescents - MEMV 1160
2.25 AMA PRA Category 1 Credits TM from June 12, 2017 thru June 12, 2021
This program is intended to educate physicians about the need to provide tobacco/nicotine counseling. It will cover current and future pharmacological options for tobacco/nicotine cessation, as well as behavioral treatments for nicotine dependence. The program will also illustrate practical skills for counseling adolescent patients about tobacco /nicotine products and providing age-appropriate prevention/cessation resources.
Sepsis and Oncology Training Module - T1013-E
1.0 AMA PRA Category 1 CreditsTM from June 11, 2020 to June 11, 2021
This program will explore the unique complexities of sepsis in the cancer patient and will discuss sepsis screening, identification and treatment in this population. The goal of the activity is to ensure that clinicians caring for cancer patients understand the heightened susceptibility of cancer patients to sepsis and the resulting need for consistent screening.
2.00 AMA PRA Category 1 CreditTM from December 4, 2019 thru December 4, 2020
The curriculum is designed for hematologist/oncologists, nurse practitioners/physician assistants, pharmacists, and other health care providers and its collectively titled Targeting B-cell Maturation Antigen in Relapsed/Refractory Multiple Myeloma: New Findings in Clinical Context. The overarching goal of the education is to improve awareness, knowledge, and eventual competence in the use of novel therapies that target BCMA in the treatment of relapsed/refractory multiple myeloma.
If you have any questions or concerns regarding Online CME, please contact:
Angie Castillo
Sr. Conference Coordinator
Telephone: 832-750-1069
Email: angelicc@mdanderson.org
Kristi J. English, CHCP
Manager
Telephone: 713-563-7494
Email: kjenglish@mdanderson.org